Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4321 to 4335 of 8314 results

  1. Stroke risk assessment: Can routine data from UK primary care databases clarify stroke risk in people with atrial fibrillation according to baseline risk factors and treatment?

    Recommendation ID NG196/7 Question Stroke risk assessment: Can routine data from UK primary care databases clarify stroke risk in people

    Research recommendation
    Published
    10 August 2021

  2. Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)?

    Recommendation ID CG186/5 Question Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)? Any explanatory

    Research recommendation
    Published
    9 June 2015

  3. Weight loss for managing pelvic floor dysfunction: Can weight loss reduce symptoms of pelvic floor dysfunction in women who are overweight or obese?

    Recommendation ID NG210/11 Question Weight loss for managing pelvic floor dysfunction: Can weight loss reduce symptoms of pelvic floor

    Research recommendation
    Published
    7 January 2022

  4. What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia compared with other pharmacological treatments?

    Recommendation ID CG173/3 Question What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia

    Research recommendation
    Published
    26 October 2020

  5. Carbamazepine for treating trigeminal neuralgia:- What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia compared with other pharmacological treatments?

    Recommendation ID CG173/3 Question Carbamazepine for treating trigeminal neuralgia:- What is the clinical and cost effectiveness of carbamazepine

    Research recommendation
    Published
    9 June 2015

  6. The evidence on cardiac contractility modulation device implantation for heart failure raises no major safety concerns. However, the evidence on efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of  research .

    Recommendation ID IPG655 Question The evidence on cardiac contractility modulation device implantation for heart failure raises no major

    Research recommendation
    Published
    15 November 2019

  7. Cardiac rehabilitation:- Is an 8-week, comprehensive, multidisciplinary, cardiac rehabilitation service more clinically and cost effective for managing stable angina than current clinical practice?

    Recommendation ID CG126/4 Question Cardiac rehabilitation:- Is an 8-week, comprehensive, multidisciplinary, cardiac rehabilitation service

    Research recommendation
    Published
    9 June 2015

  8. What is the utility of routine cardiovascular evaluation for asymptomatic people with FH?

    Recommendation ID CG71/6 Question What is the utility of routine cardiovascular evaluation for asymptomatic people with FH? Any

    Research recommendation
    Published
    15 November 2019

  9. Audit:- What is the clinical and cost effectiveness of collecting long-term outcomes in a national trauma audit system?

    Recommendation ID NG40/1 Question Audit:- What is the clinical and cost effectiveness of collecting long-term outcomes in a national trauma

    Research recommendation
    Published
    4 April 2016

  10. Augmentative and alternative communication:- What is the current pattern of provision and use of augmentative and alternative communication (AAC) by people with motor neurone disease (MND) in England?

    Recommendation ID NG42/6 Question Augmentative and alternative communication:- What is the current pattern of provision and use of augmentative

    Research recommendation
    Published
    21 March 2016

  11. Awareness raising:- What is the effectiveness and cost effectiveness of different methods of awareness raising about air pollution (including air pollution alerts) on people's behaviour and on acute and chronic health outcomes?

    Recommendation ID NG70/5 Question Awareness raising:- What is the effectiveness and cost effectiveness of different methods of awareness

    Research recommendation
    Published
    12 October 2018

  12. Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate

    Research recommendation
    Published
    22 January 2021

  13. Long-term risk of renal scarring and impaired renal function: A well designed cohort study investigating long-term outcomes including renal scarring and renal function of children who have had UTI should be conducted in the UK.

    Recommendation ID NG224/02 Question Long-term risk of renal scarring and impaired renal function: A well designed cohort study investigating

    Research recommendation
    Published
    4 August 2022

  14. Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus

    Research recommendation
    Published
    22 January 2021

  15. Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance misuse to obtain an optimal service (including optimal time frame for delivering interventions) to meet their needs and enable their recovery?

    Recommendation ID NG58/4 Question Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting

    Research recommendation
    Published
    10 February 2017